Synta Pharmaceuticals CEO Paul Friedman's 2018 pay jumps 312% to $5.6M

Synta Pharmaceuticals reports 2018 executive compensation

By ExecPay News

Published: May 15, 2019

Synta Pharmaceuticals reported fiscal year 2018 executive compensation information on May 15, 2019.
In 2018, three executives at Synta Pharmaceuticals received on average a compensation package of $4.4M, a 289% increase compared to previous year.
Average pay of disclosed executives at Synta Pharmaceuticals
Paul A. Friedman, Chief Executive Officer, received $5.6M in total, which increased by 312% compared to 2017. 87.19% of Friedman's compensation, or $4.9M, was in option awards. Friedman also received $304.5K in non-equity incentive plan and $416.7K in salary.
For fiscal year 2018, the median employee pay was $804,000 at Synta Pharmaceuticals. Therefore, the ratio of Paul A. Friedman's pay to the median employee pay was 7 to one.
Rebecca Taub, Chief Medical Officer, received a compensation package of $4.3M, which increased by 298% compared to previous year. 85.93% of the compensation package, or $3.7M, was in option awards.
Marc R. Schneebaum, Chief Financial Officer, earned $3.4M in 2018, a 247% increase compared to previous year.

Related executives

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on May 15, 2019.